DEVELOPMENT OF A GUT MICROBIOME-BASED PROGNOSTIC SIGNATURE PREDICTING RISK OF HEPATOCELLULAR CANCER RECURRENCE AFTER ABLATIVE THERAPIES

University Of Alabama At Birmingham, Birmingham AL

Investigators